Open Access
Experimental Antiviral Therapeutic Studies for Human Rhinovirus Infections
Publication type: Journal Article
Publication date: 2021-07-09
scimago Q2
SJR: 0.829
CiteScore: 8.2
Impact factor: —
ISSN: 11791454
PubMed ID:
34276229
Pharmacology
Molecular Medicine
Pharmacology (medical)
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
|
|
|
Viruses
2 publications, 6.9%
|
|
|
Antiviral Research
2 publications, 6.9%
|
|
|
American Journal of Respiratory and Critical Care Medicine
1 publication, 3.45%
|
|
|
Pharmaceutics
1 publication, 3.45%
|
|
|
Nutrients
1 publication, 3.45%
|
|
|
Pharmaceuticals
1 publication, 3.45%
|
|
|
ACS Applied Bio Materials
1 publication, 3.45%
|
|
|
Annual Reports in Medicinal Chemistry
1 publication, 3.45%
|
|
|
Expert Review of Clinical Immunology
1 publication, 3.45%
|
|
|
Current Opinion in Infectious Diseases
1 publication, 3.45%
|
|
|
Respiratory Research
1 publication, 3.45%
|
|
|
Journal of Biomolecular Structure and Dynamics
1 publication, 3.45%
|
|
|
Virology Journal
1 publication, 3.45%
|
|
|
Nature Reviews Immunology
1 publication, 3.45%
|
|
|
Open Forum Infectious Diseases
1 publication, 3.45%
|
|
|
Scientific Reports
1 publication, 3.45%
|
|
|
DARU, Journal of Pharmaceutical Sciences
1 publication, 3.45%
|
|
|
International Journal of COPD
1 publication, 3.45%
|
|
|
Methods in Molecular Biology
1 publication, 3.45%
|
|
|
CMI Communications
1 publication, 3.45%
|
|
|
Journal of Molecular Graphics and Modelling
1 publication, 3.45%
|
|
|
Annals of Allergy, Asthma and Immunology
1 publication, 3.45%
|
|
|
Indian Journal of Medical Microbiology
1 publication, 3.45%
|
|
|
Mediators of Inflammation
1 publication, 3.45%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
6
7
8
|
|
|
Elsevier
8 publications, 27.59%
|
|
|
Springer Nature
6 publications, 20.69%
|
|
|
MDPI
5 publications, 17.24%
|
|
|
Taylor & Francis
3 publications, 10.34%
|
|
|
American Thoracic Society
1 publication, 3.45%
|
|
|
American Chemical Society (ACS)
1 publication, 3.45%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 3.45%
|
|
|
Oxford University Press
1 publication, 3.45%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 3.45%
|
|
|
Hindawi Limited
1 publication, 3.45%
|
|
|
1
2
3
4
5
6
7
8
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
29
Total citations:
29
Citations from 2024:
14
(48.28%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Coultas J. A. et al. Experimental Antiviral Therapeutic Studies for Human Rhinovirus Infections // Journal of Experimental Pharmacology. 2021. Vol. Volume 13. pp. 645-659.
GOST all authors (up to 50)
Copy
Coultas J. A., Cafferkey J., Mallia P., Johnston S. L. Experimental Antiviral Therapeutic Studies for Human Rhinovirus Infections // Journal of Experimental Pharmacology. 2021. Vol. Volume 13. pp. 645-659.
Cite this
RIS
Copy
TY - JOUR
DO - 10.2147/jep.s255211
UR - https://doi.org/10.2147/jep.s255211
TI - Experimental Antiviral Therapeutic Studies for Human Rhinovirus Infections
T2 - Journal of Experimental Pharmacology
AU - Coultas, James Andrew
AU - Cafferkey, John
AU - Mallia, Patrick
AU - Johnston, Sebastian L.
PY - 2021
DA - 2021/07/09
PB - Taylor & Francis
SP - 645-659
VL - Volume 13
PMID - 34276229
SN - 1179-1454
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Coultas,
author = {James Andrew Coultas and John Cafferkey and Patrick Mallia and Sebastian L. Johnston},
title = {Experimental Antiviral Therapeutic Studies for Human Rhinovirus Infections},
journal = {Journal of Experimental Pharmacology},
year = {2021},
volume = {Volume 13},
publisher = {Taylor & Francis},
month = {jul},
url = {https://doi.org/10.2147/jep.s255211},
pages = {645--659},
doi = {10.2147/jep.s255211}
}